This short-term study demonstrates the safety and feasibility of up to 246 million MPCs in subjects with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Skyler et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: